Antibiotic use in infants may be linked to development of celiac disease in childhoodStudy finds early exposure to systemic antibiotics might be a risk factor for celiac disease Canada to study the safety and effectiveness of biosimilars compared to reference biologic drugs Five-year study will examine real-world comparative efficacy and safety in rheumatologic conditions and inflammatory bowel disease. New Canadian consensus guidelines for managing irritable bowel syndrome Aim to help optimize the use of existing medical therapies and their sequence of use How to manage bleeding risk with serotonin reuptake inhibitor antidepressants Review examines risk factors and outlines strategies to mitigate bleeding risk New Canadian consensus guidelines for colorectal cancer screening Provide guidance for individuals with a family history of nonhereditary colorectal cancer or adenoma Health Canada approves rifaximin (Zaxine) for treating irritable bowel syndrome with diarrhea Two-week course reduces common IBS-D symptoms, including bloating, abdominal pain and diarrhea Esomeprazole switching from Schedule II to Schedule III status in Canada To be available for self-selection for once-daily 14-day treatment of frequent heartburn New Canadian guidelines for treatment of Clostridium difficile infection Provide recommendations for the management of initial and recurrent episodes Is ondansetron safe to use during pregnancy? Systematic review examines ondansetron safety for treating nausea and vomiting in pregnancy Can early exposure to anti-TNF therapy reduce the risk of Parkinson disease? Study suggests reducing systemic inflammation in patients with inflammatory bowel disease can also decrease the incidence of Parkinson disease First Previous 13 14 15 16 17 Next Last
